UTRECHT, The Netherlands and PHILADELPHIA, Nov. 16, 2022 (GLOBE NEWSWIRE) — LAVA Therapeutics N.V. (Nasdaq: LVTX), a clinical-stage immuno-oncology company focused on developing its proprietary Gammabody™ platform of bispecific gamma delta T cell engagers, today announced recent corporate highlights and financial results for the third quarter ended September ...Read more

LVTX News on the Web

2022-11-25

Can LAVA Therapeutics N.V. (LVTX) Climb 198% to Reach the Level Wall Street Analysts Expect?

Zacks

Neutral

2022-11-22

Analysts’ Top Healthcare Picks: Enanta Pharmaceuticals (ENTA), Mirati Therapeutics (MRTX)

TipRanks News

Bullish

2022-11-17

LAVA Therapeutics N.V. Up 1.04% To $4.85 After Earnings Beat

Investors Observer

Bullish

2022-11-17

Analysts Are Bullish on These Healthcare Stocks: Vyant Bio (VYNT), Cybin (CYBN)

TipRanks News

Neutral

2022-11-16

LAVA Therapeutics N.V. (LVTX) Q3 Earnings Surpass Estimates

Zacks

Neutral

2022-11-16

LAVA Therapeutics Provides Business Update and Reports Third Quarter Financial Results

Yahoo Finance

Bullish

2022-11-14

Will LAVA Therapeutics N.V. (LVTX) Report Negative Q3 Earnings? What You Should Know

Zacks

Neutral

2022-11-14

Viridian Therapeutics, Inc. (VRDN) Reports Q3 Loss, Tops Revenue Estimates

Zacks

Neutral

News Score - Last 7 Days

Neutral

LVTX

Sector Average

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

Healthcare Stocks that are Trending in the News

RIGLRigel

HZNPHorizon Therapeutics

APENApollo Endosurgery

CINCCincor Pharma

IRMDIradimed

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing